Skip to content

Evaluation the effect two different material with or with out PRGF on the bone formation in maxillary finus graft

Evaluation the effect of OSTEON II with or with out PRGF on the bone formation in maxillary sinus graft

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201203119260N1
Enrollment
14
Registered
2014-04-13
Start date
2013-11-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athrophic ridge in posterior of maxilla. Disorder of bone density and structure, unspecified

Interventions

Intervention 1: Intervention: add of the PRGF (plasma rich in grow th factor) to osteon II granules in maxillary sinus grafting maxillary sinus garfting in both of intevention and control group perfo
Treatment - Drugs
Intervention: add of the PRGF (plasma rich in grow th factor) to osteon II granules in maxillary sinus grafting maxillary sinus garfting in both of intevention and control group perform. It will star
Osteon II granules for grafting maxillary sinus as control group

Sponsors

Islamic Azad university tehtan Dental Branch
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criterion: minimal 5 millimeter bone height. Exclusion criteria: acute infection; the use of more than 10 cigaret in a day; treatment with bisphosphonate; uncontrolled diabetes; pregnancy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Amount of bone. Timepoint: 6 month. Method of measurement: Histology.

Secondary

MeasureTime frame
Foreign body reaction, quality of the bone(lamellar/woven), retained grafting material. Timepoint: 6 month. Method of measurement: Histology.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPejman Mahmoodi

Islamic Azad University, Tehtan Dental Branch

pejman.mahmoodi.812gmail.com+98 21 2206 2022

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026